153 related articles for article (PubMed ID: 23392461)
1. The cost-effectiveness of repeat HIV testing during pregnancy in a resource-limited setting.
Kim LH; Cohan DL; Sparks TN; Pilliod RA; Arinaitwe E; Caughey AB
J Acquir Immune Defic Syndr; 2013 Jun; 63(2):195-200. PubMed ID: 23392461
[TBL] [Abstract][Full Text] [Related]
2. Point-of-care HIV viral load in pregnant women without prenatal care: a cost-effectiveness analysis.
Avram CM; Greiner KS; Tilden E; Caughey AB
Am J Obstet Gynecol; 2019 Sep; 221(3):265.e1-265.e9. PubMed ID: 31229430
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of HIV and syphilis antenatal screening: a modelling study.
Bristow CC; Larson E; Anderson LJ; Klausner JD
Sex Transm Infect; 2016 Aug; 92(5):340-6. PubMed ID: 26920867
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of HIV rescreening during late pregnancy to prevent mother-to-child HIV transmission in South Africa and other resource-limited settings.
Soorapanth S; Sansom S; Bulterys M; Besser M; Theron G; Fowler MG
J Acquir Immune Defic Syndr; 2006 Jun; 42(2):213-21. PubMed ID: 16639346
[TBL] [Abstract][Full Text] [Related]
5. Perinatal HIV transmission and the cost-effectiveness of screening at 14 weeks gestation, at the onset of labour and the rapid testing of infants.
Udeh B; Udeh C; Graves N
BMC Infect Dis; 2008 Dec; 8():174. PubMed ID: 19117527
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of interventions to reduce vertical HIV transmission from pregnant women who have not received prenatal care.
Mrus JM; Tsevat J
Med Decis Making; 2004; 24(1):30-9. PubMed ID: 15005952
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago.
Immergluck LC; Cull WL; Schwartz A; Elstein AS
Pediatrics; 2000 Apr; 105(4):E54. PubMed ID: 10742375
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus retesting during pregnancy: costs and effectiveness in preventing perinatal transmission.
Sansom SL; Jamieson DJ; Farnham PG; Bulterys M; Fowler MG
Obstet Gynecol; 2003 Oct; 102(4):782-90. PubMed ID: 14551009
[TBL] [Abstract][Full Text] [Related]
9. Universal antenatal human immunodeficiency virus (HIV) testing programme is cost-effective despite a low HIV prevalence in Hong Kong.
Lee PM; Wong KH
Hong Kong Med J; 2007 Jun; 13(3):199-207. PubMed ID: 17548908
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African Developing country setting.
Mansergh G; Haddix AC; Steketee RW; Nieburg PI; Hu DJ; Simonds RJ; Rogers M
JAMA; 1996 Jul; 276(2):139-45. PubMed ID: 8656506
[TBL] [Abstract][Full Text] [Related]
11. [A comparison of three screening strategies for prevention of perinatal HIV infection in Colombia: a decision analysis model].
Gómez M
Rev Panam Salud Publica; 2008 Oct; 24(4):256-64. PubMed ID: 19133174
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of integrated routine offering of prenatal HIV and syphilis screening in China.
Owusu-Edusei K; Tao G; Gift TL; Wang A; Wang L; Tun Y; Wei X; Wang L; Fuller S; Kamb ML; Bulterys M
Sex Transm Dis; 2014 Feb; 41(2):103-10. PubMed ID: 24413489
[TBL] [Abstract][Full Text] [Related]
13. The cost effectiveness of universal antenatal screening for HIV in New Zealand.
Bramley D; Graves N; Walker D
AIDS; 2003 Mar; 17(5):741-8. PubMed ID: 12646798
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of voluntary prenatal and routine newborn HIV screening.
AIDS Read; 2001 Feb; 11(2):81. PubMed ID: 11279876
[No Abstract] [Full Text] [Related]
15. Cost-effectiveness of HIV screening for incarcerated pregnant women.
Resch S; Altice FL; Paltiel AD
J Acquir Immune Defic Syndr; 2005 Feb; 38(2):163-73. PubMed ID: 15671801
[TBL] [Abstract][Full Text] [Related]
16. A comparative analysis of costs of single and dual rapid HIV and syphilis diagnostics: results from a randomised controlled trial in Colombia.
Obure CD; Gaitan-Duarte H; Losada Saenz R; Gonzalez L; Angel-Muller E; Laverty M; Perez F
Sex Transm Infect; 2017 Nov; 93(7):482-486. PubMed ID: 28495681
[TBL] [Abstract][Full Text] [Related]
17. Routine prenatal screening for HIV in a low-prevalence setting.
Patrick DM; Money DM; Forbes J; Dobson SR; Rekart ML; Cook DA; Middleton PJ; Burdge DR
CMAJ; 1998 Oct; 159(8):942-7. PubMed ID: 9834719
[TBL] [Abstract][Full Text] [Related]
18. The cost-effectiveness of voluntary intrapartum rapid human immunodeficiency virus testing for women without adequate prenatal care.
Grobman WA; Garcia PM
Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 1):1062-71. PubMed ID: 10561619
[TBL] [Abstract][Full Text] [Related]
19. The cost-effectiveness of elective Cesarean delivery for HIV-infected women with detectable HIV RNA during pregnancy.
Mrus JM; Goldie SJ; Weinstein MC; Tsevat J
AIDS; 2000 Nov; 14(16):2543-52. PubMed ID: 11101066
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of dual maternal HIV and syphilis testing strategies in high and low HIV prevalence countries: a modelling study.
Rodriguez PJ; Roberts DA; Meisner J; Sharma M; Owiredu MN; Gomez B; Mello MB; Bobrik A; Vodianyk A; Storey A; Githuka G; Chidarikire T; Barnabas R; Barr-Dichiara M; Jamil MS; Baggaley R; Johnson C; Taylor MM; Drake AL
Lancet Glob Health; 2021 Jan; 9(1):e61-e71. PubMed ID: 33227254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
